​

Twist Bioscience (TWST) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Twist Bioscience Revenue Highlights

Latest Revenue (Y)

$376.57M

0

Main Segment (Y)

Ngs Tools

Main Geography (Y)

Americas

Twist Bioscience Revenue by Period

Twist Bioscience Revenue by Year

DateRevenueChange
2025-09-30$376.57M20.32%
2024-09-30$312.97M27.69%
2023-09-30$245.11M20.41%
2022-09-30$203.56M53.83%
2021-09-30$132.33M46.87%
2020-09-30$90.10M65.67%
2019-09-30$54.38M113.89%
2018-09-30$25.43M136.16%
2017-09-30$10.77M374.53%
2016-09-30$2.27M-

Twist Bioscience generated $376.57M in revenue during NA 2025, up 20.32% compared to the previous quarter, and up 417.95% compared to the same period a year ago.

Twist Bioscience Revenue by Quarter

DateRevenueChange
2025-06-30--100.00%
2025-03-31$92.79M4.60%
2024-12-31$88.71M4.73%
2024-09-30$84.71M3.98%
2024-06-30$81.46M8.18%
2024-03-31$75.30M5.32%
2023-12-31$71.50M6.80%
2023-09-30$66.95M5.03%
2023-06-30$63.74M5.92%
2023-03-31$60.18M10.95%
2022-12-31$54.24M-5.34%
2022-09-30$57.31M2.13%
2022-06-30$56.11M16.59%
2022-03-31$48.13M14.54%
2021-12-31$42.02M10.72%
2021-09-30$37.95M8.38%
2021-06-30$35.02M12.22%
2021-03-31$31.20M10.81%
2020-12-31$28.16M-13.17%
2020-09-30$32.43M52.93%
2020-06-30$21.21M9.90%
2020-03-31$19.30M12.43%
2019-12-31$17.16M9.07%
2019-09-30$15.74M15.71%
2019-06-30$13.60M0.32%
2019-03-31$13.56M17.97%
2018-12-31$11.49M36.70%
2018-09-30$8.41M28.53%
2018-06-30$6.54M6.08%
2018-03-31$6.17M42.96%
2017-12-31$4.31M24.44%
2017-09-30$3.47M9.13%
2017-06-30$3.18M-

Twist Bioscience generated - in revenue during Q3 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Twist Bioscience Revenue Breakdown

Twist Bioscience Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceSep 25Sep 24Sep 23Sep 22Sep 21
Dna And Biopharma Libraries$11.18M$13.93M$10.20M$6.15M$12.66M
Ngs Tools$208.10M$169.13M$123.71M$99.31M$72.67M
Oligo Pools$20.23M$16.91M$14.49M$12.42M$8.04M
Synthetic Genes$113.60M$92.68M$73.54M$61.51M$38.96M
Antibody Discovery$23.45M$20.33M$23.17M$24.17M-

Twist Bioscience's latest annual revenue breakdown by segment (product or service), as of Sep 25: Ngs Tools (55.26%), Synthetic Genes (30.17%), Antibody Discovery (6.23%), Oligo Pools (5.37%), and Dna And Biopharma Libraries (2.97%).

Quarterly Revenue by Product

Product/ServiceSep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
Synthetic Genes$31.21M$27.68M$28.22M$26.48M$25.65M$24.95M$22.36M$19.73M$20.05M$19.30M$18.01M$16.18M$16.42M$17.40M$14.16M$13.53M$9.74M$11.16M$9.19M$8.87M
Oligo Pools$5.00M$5.42M$4.71M$5.09M$4.61M$4.17M$3.94M$4.19M$3.74M$3.73M$3.31M$3.70M$3.67M$3.26M$2.31M$3.19M$2.67M$2.02M$1.84M$1.51M
Ngs Tools$53.03M$55.28M$51.15M$48.64M$45.54M$43.40M$40.77M$39.42M$37.11M$33.24M$28.99M$24.36M$29.19M$27.79M$23.10M$19.23M$21.45M$18.70M$16.95M-
Dna And Biopharma Libraries$3.32M$2.06M$3.02M$2.79M$3.62M$3.85M$3.53M$2.94M$2.66M$2.88M$2.83M$1.84M$1.50M$1.42M$1.97M$1.26M$4.10M$3.14M$3.22M-
Antibody Discovery$6.44M$5.61M$5.70M$5.70M$5.30M$5.10M$4.70M$5.23M$3.39M$4.58M$7.03M$8.17M$6.53M$6.24M$6.59M$4.81M----
DNA And Biopharma Libraries-------------------$2.21M
NGS Tools-------------------$15.57M

Twist Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Ngs Tools (53.56%), Synthetic Genes (31.53%), Antibody Discovery (6.51%), Oligo Pools (5.05%), and Dna And Biopharma Libraries (3.35%).

Twist Bioscience Revenue Breakdown by Country

Annual Revenue by Country

CountrySep 25Sep 24Sep 23Sep 22Sep 21
EMEA$124.24M$92.57M$71.39M$62.08M-
Asia Pacific$26.75M$26.52M$22.46M$19.01M$10.30M
Americas$225.58M$193.88M$151.26M$122.47M$77.91M
E M E A----$44.12M

Twist Bioscience's latest annual revenue breakdown by geography, as of Sep 25: Americas (59.90%), EMEA (32.99%), and Asia Pacific (7.10%).

Quarterly Revenue by Country

CountrySep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
Americas$57.30M$59.39M$55.19M$53.71M$52.66M$51.39M$45.87M$43.96M$43.68M$39.02M$34.92M$33.65M$34.84M$35.80M$28.46M$22.61M$76.58M$544.00K$484.00K$302.00K
EMEA$34.55M$30.74M$30.64M$28.30M$25.50M$23.58M$22.26M$21.22M$17.21M$19.07M$18.78M$16.33M$16.87M$15.48M$15.20M$9.06M----
Asia Pacific$7.16M$5.93M$6.96M$6.70M$6.54M$6.49M$7.17M$6.32M$6.06M$5.66M$6.47M$4.27M$5.60M$4.83M$4.46M$4.04M$2.77M$3.10M$2.67M$1.77M
E M E A---------------$15.37M$12.43M$12.66M$9.98M-
U-----------------$18.72M$18.08M-
UNITED STATES-------------------$17.03M

Twist Bioscience's latest quarterly revenue breakdown by geography, as of Sep 25: Americas (57.87%), EMEA (34.90%), and Asia Pacific (7.23%).

Twist Bioscience Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
QDELQuidelOrtho$2.78B$699.90M
CLOVClover Health Investments$1.37B$496.65M
GRDNGuardian Pharmacy Services$1.23B$377.43M
TWSTTwist Bioscience$376.57M-
PRCTPROCEPT BioRobotics$224.50M$83.33M
QUREuniQure$27.12M$3.70M
BGMBGM Group$25.10M$12.56M
MESOMesoblast$7.50M$1.69M
GPCRStructure Therapeutics--
VRDNViridian Therapeutics-$70.57M
EWTXEdgewise Therapeutics--

TWST Revenue FAQ

What is Twist Bioscience’s yearly revenue?

Twist Bioscience's yearly revenue for 2025 was $376.57M, representing an increase of 20.32% compared to 2024. The company's yearly revenue for 2024 was $312.97M, representing an increase of 27.69% compared to 2023. TWST's yearly revenue for 2023 was $245.11M, representing an increase of 20.41% compared to 2022.

What is Twist Bioscience’s quarterly revenue?

Twist Bioscience's quarterly revenue for Q3 2025 was $0, a -100.00% decrease from the previous quarter (Q2 2025), and a -100.00% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $92.79M, a 4.60% increase from the previous quarter (Q1 2025), and a 23.23% increase year-over-year (Q2 2024). TWST's quarterly revenue for Q1 2025 was $88.71M, a 4.73% increase from the previous quarter (Q4 2024), and a 24.08% increase year-over-year (Q1 2024).

What is Twist Bioscience’s revenue growth rate?

Twist Bioscience's revenue growth rate for the last 3 years (2023-2025) was 53.63%, and for the last 5 years (2021-2025) was 184.56%.

What are Twist Bioscience’s revenue streams?

Twist Bioscience's revenue streams in p 25 are Dna And Biopharma Libraries, Ngs Tools, Oligo Pools, Synthetic Genes, and Antibody Discovery. Dna And Biopharma Libraries generated $11.18M in revenue, accounting 2.97% of the company's total revenue, down -19.73% year-over-year. Ngs Tools generated $208.1M in revenue, accounting 55.26% of the company's total revenue, up 23.05% year-over-year. Oligo Pools generated $20.23M in revenue, accounting 5.37% of the company's total revenue, up 19.66% year-over-year. Synthetic Genes generated $113.6M in revenue, accounting 30.17% of the company's total revenue, up 22.58% year-over-year. Antibody Discovery generated $23.45M in revenue, accounting 6.23% of the company's total revenue, up 15.37% year-over-year.

What is Twist Bioscience’s main source of revenue?

For the fiscal year ending Sep 25, the largest source of revenue of Twist Bioscience was Ngs Tools. This segment made a revenue of $208.1M, representing 55.26% of the company's total revenue.